Avenzo Therapeutics | $60,000,000 | (Sep 23, 2025)
Tilt(2) | $7,100,000 | (Sep 23, 2025)
Unit 221B | $5,000,000 | (Sep 23, 2025)
Certified by Founder
Lodge
INNOVENTRIC
start up
Israel
- Rehovot
- 30/10/2024
- Series B
- $28,500,000
Innoventric is a Structural Heart medical device company specializing in the development of percutaneous heterotopic cross-caval solutions for Tricuspid Regurgitation and right heart disease.
http://www.innoventric.com
#TTVR #Cardiology #MedTech #InterventionalCardiology #heterotopic #crosscaval #medicaldevices
- Industry Medical Device
- Website https://innoventric.com/
- LinkedIn https://www.linkedin.com/company/innoventric/
Circuit & Chisel | $19,200,000 | (Sep 23, 2025)
Scindo | $5,403,032 | (Sep 23, 2025)
DaltonTx | $5,402,820 | (Sep 23, 2025)
Mycroft | $3,500,000 | (Sep 23, 2025)
TextYess | $2,833,546 | (Sep 23, 2025)
Sunhat | $10,859,404 | (Sep 23, 2025)
Earthmover PBC | $7,200,000 | (Sep 23, 2025)
Titan Exchange | $7,000,000 | (Sep 23, 2025)
Le Walk | $4,100,000 | (Sep 23, 2025)